Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 90

Sort by

Sort Order Select

Journal Articles

Follicular Lymphoma Frontline Immuno-Chemotherapy: Survival Outcomes and Infection-Related Morbidity

Faouzi Djebbari, Furqaan Kaji, Louise Stanton, Graham P. Collins, MA, MBBS, MRCP, FRCPath, DPhil, Toby A. Eyre

Blood (2019) 134 (Supplement_1): 5884.

https://doi.org/10.1182/blood-2019-122213

Published: 2019

Journal Articles

Patient Perception on Health Care Delivery for Sickle Cell Disease and Opportunities for Quality Improvement

Ofelia A. Alvarez, MD, Sandra Echenique, Hector Rodriguez-Cortes, MD, Thomas J. Harrington, MD, E. Leila Jerome Clay, MD MCTS, FAAP, Vandy Black, MDMSc, Mary Murph, Christopher Wells, Ifeyinwa (ify) Osunkwo, MDMPH

Blood (2019) 134 (Supplement_1): 5862.

https://doi.org/10.1182/blood-2019-123215

Published: 2019

Journal Articles

Hydroxyurea Prescription Fills and Adherence, Among Pediatric and Adult Medicaid Eligible Patients with Sickle Cell Disease in North Carolina

Nirmish Shah, Christian Douglas, DrPH, Nancy Crego, PhD RN, CCRN, CHSE, Emily Bonnabeau, BA, Marian Earls, MD, Kern Eason, MBA, Elizabeth Merwin, PhD RN, FAAN, Paula Tanabe, PhDRN

Blood (2019) 134 (Supplement_1): 3391.

https://doi.org/10.1182/blood-2019-124442

Published: 2019

Journal Articles

Beliefs and Practices Among Adults with Sickle Cell Disease Regarding Reproductive Health Decisions and Family Planning

Laura Ibidunni, Kristin Paulyson Nunez, MS, CGC, Jude C Jonassaint, RN, Laura De Castro, MD MHSc

Blood (2019) 134 (Supplement_1): 2101.

https://doi.org/10.1182/blood-2019-122255

Published: 2019

Journal Articles

Infection-Related Morbidity Reduced Overall Survival in a Large Real-World Cohort of Transplant Ineligible Newly Diagnosed Myeloma Patients Treated with UK Standard of Care

Faouzi Djebbari, Fotios Panitsas, Catherine Prodger, Fearn Davies, Kieran Burton, Akhil Khera, Grant Vallance, B.Sc., PhD, Sally Moore, Jaimal Kothari, Andy Peniket, MD, Karthik Ramasamy, MD PhD

Blood (2019) 134 (Supplement_1): 4768.

https://doi.org/10.1182/blood-2019-128139

Published: 2019

Journal Articles

Programmed Cell Death Receptor (PD-1), PD-1 Ligand (PD-L1) Expression in Philadelphia Chromosome Negative Myeloid Neoplasms

Chi Chen, MD PhD, Anita Pandey, MBBS, MD, Ajay Kundra, MD, Sreenath Kodali, MBBS, MD, Ching Wong, MD, Tony W. Cheung, MD, Vladimir K. Gotlieb, MD, Gardith Joseph, MD, Sophia Tribie, Jen-Chin Wang, MD

Blood (2018) 132 (Supplement 1): 4302.

https://doi.org/10.1182/blood-2018-99-112393

Published: 2018

Journal Articles

Healthcare Utilization Patterns and Health Quality Indicators in Sickle Cell Disease Patients Transitioning from Pediatric to Adulthood

Akshaya Arjunan, BS, Deborah Moss, MD MPH, Laura M. De Castro, MD

Blood (2018) 132 (Supplement 1): 3513.

https://doi.org/10.1182/blood-2018-99-117558

Published: 2018

Journal Articles

Opportunistic Infections, Is Non Hodgkin Lymphoma One of the Risk Factors for Mortality?

Karan Jatwani, MBBS, Shraddha Jatwani, MBBS, MD, Sridevi Rajeeve, MD, Karan Chugh, MBBS, MD, Rakesh Kumar Sharma, MBBS, MD, Stuthi Perimbeti, MD MPH, Vivek Suresh Modi, MBBS, Siva Krishna Mannem, MBBS

Blood (2018) 132 (Supplement 1): 5818.

https://doi.org/10.1182/blood-2018-99-120214

Published: 2018

Journal Articles

Outpatient Healthcare Utilization and Rates of Co-Management Among Medicaid Patients with Sickle Cell Disease in North Carolina

Nirmish Shah, MD, Christian Douglas, DrPH, Emily Bonnabeau, BA, Nancy Crego, PhD RN, CCRN, CHSE, Marian Earls, MD, Kern Eason, MBA, Elizabeth Merwin, PhD RN, FAAN, Paula Tanabe, PhD MSN, MPH, RN, FAEN, FAAN

Blood (2018) 132 (Supplement 1): 4725.

https://doi.org/10.1182/blood-2018-99-110737

Published: 2018

Journal Articles

Evidence Based Recommendations for Supportive Care in Multiple Myeloma

Anum Qureshi, Muhammad Junaid Tariq, MD, Zunairah Shah, MBBS, Muhammad Abu Zar, MD, Shehroz Aslam, MD, Abdul Rafae, MD, Mustafa Nadeem Malik, MD, Ahmad Kamal, MD, Jemin Aby Jose, MD, Insija Ilyas Selene, MBBS, Madeeha Shafqat, Faiza Jamil, MD, Seren Durer, MD, Ceren Durer, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 1952.

https://doi.org/10.1182/blood-2018-99-110748

Published: 2018

Journal Articles

Safety, Tolerability and Response Rates of Daratumumab in Patients with Relapsed Light Chain (AL) Amyloidosis: Results of a Phase II Study

Vaishali Sanchorawala, MD, Shayna Sarosiek, MD, John Mark Sloan, MD, Dina Brauneis, NP, Mary Ellen Migre, Meredith Mistark, Stephanie Santos, Ramon Cruz, Salli Fennessey, Anthony C Shelton, RN

Blood (2018) 132 (Supplement 1): 2005.

https://doi.org/10.1182/blood-2018-99-112991

Published: 2018

Journal Articles

The Conundrum of Hydroxyurea Use and Health Care Utilization in Sickle Cell Disease

Akshaya Arjunan, BS, Deborah Moss, MD MPH, Sydna B. Burns, Laura M. De Castro, MD

Blood (2018) 132 (Supplement 1): 2282.

https://doi.org/10.1182/blood-2018-99-117735

Published: 2018

Journal Articles

Diagnostics of Pulmonary Aspergillosis in Critically Ill Hematological and Non-Hematological Patients in the Intensive Care Unit By Combined Use of Galactomannan, 1-3-Beta-D-Glucan, Aspergillus Specific PCR and Conventional Culture in Concurrent Blood and Bronchoalveolar Lavage Samples — Results of a Multicenter Prospective Pilot Study

Tobias Boch, MD, Birgit Spiess, Tobias Liebregts, Peter Schellongowski, Patrick Meybohm, Peter-Michael Rath, Jörg Steinmann, Simone Britsch, Jabbour Claude, Julia Michels, Wolf-Karsten Hofmann, MD, Mark Reinwald, Dieter Buchheidt

Blood (2017) 130 (Supplement 1): 3456.

https://doi.org/10.1182/blood.V130.Suppl_1.3456.3456

Published: 2017

Journal Articles

Diagnosing and Managing Plasma Cell Disorders: Education Gaps in Primary Care Providers and Hematologist/Oncologists

Emily S Van Laar, Robert Z. Orlowski, MD PhD, Davecia Cameron, MSc, Steven W Ressler, MD, Joseph R Mikhael, MD FRCPC, MD

Blood (2017) 130 (Supplement 1): 5606.

https://doi.org/10.1182/blood.V130.Suppl_1.5606.5606

Published: 2017

Journal Articles

Impact of Pneumococcal Vaccination on Multiple Myeloma

Blood (2017) 130 (Supplement 1): 1871.

https://doi.org/10.1182/blood.V130.Suppl_1.1871.1871

Published: 2017

Journal Articles

Using Project Echo Telementoring to Improve Sickle Cell Disease Care in the Midwest

Lisa Marie Shook, MA, MCHES, Christina Bennett Farrell, MPH, Karen A. Kalinyak, MD, Stephen C Nelson, MD, Brandon M. Hardesty, MD, Angeli Rampersad, MD, Kay Linn Saving, MD, Wanda Witten-Shurney, Julie Panepinto, Trisha Calabrese, MPH, Lori E. Crosby, PsyD, Russell E. Ware, MD PhD

Blood (2016) 128 (22): 5923.

https://doi.org/10.1182/blood.V128.22.5923.5923

Published: 2016

Journal Articles

Multiple Myeloma Vaccination Sequential Immune Response Pilot Study

Michael A Thompson, MD PhD, Martin K Oaks, PhD, John O Richards, PhD, Maharaj Singh, PhD, Thomas S Smith, BS, Karen M Michel, BS, Andinet W Alemu, MD, Michael P. Mullane, MD, Husam S Tarawneh, MD, Angela M Kraut, Kayla J Hamm, Carla Fuentes

Blood (2016) 128 (22): 5607.

https://doi.org/10.1182/blood.V128.22.5607.5607

Published: 2016

Journal Articles

Examining the Role of Bronchoscopy in Patients with Hematological Malignancies

Nakul Singhal, MD, Rashi Sharma, MD, Ashwin Chandar, MD, Vincent McAuliffe, MD, Dennis L Cooper, MD

Blood (2016) 128 (22): 2412.

https://doi.org/10.1182/blood.V128.22.2412.2412

Published: 2016

Journal Articles

Use of Marijuana in Patients with Sickle Cell Disease Increased the Frequency of Hospitalization for Acute Painful Vaso-Occlusive Crises

Samir K. Ballas, MD

Blood (2016) 128 (22): 2498.

https://doi.org/10.1182/blood.V128.22.2498.2498

Published: 2016

Journal Articles

Retrospective Analysis of Seasonal Respiratory Viral Infections (SRVI) in Hematology, Lymphoma and Oncology Patients

Samar Kulkarni, MD MRCP, FRCPath, Stephanie Michail, MBBS, Charlotte Smith, MSc, Joanna Tomlins, MSc, John Murray, BSc (hons), MSc, Michael Dennis, FRCPath, Jim Cavet, FRCPath, Tim Somervaille, MD PhD, Daniel Wiseman, FRCPath, Anna Z Castleton, FRCPath, Adrian Bloor

Blood (2016) 128 (22): 4608.

https://doi.org/10.1182/blood.V128.22.4608.4608

Published: 2016

NARROW

Follicular Lymphoma Frontline Immuno-Chemotherapy: Survival Outcomes and Infection-Related Morbidity

Patient Perception on Health Care Delivery for Sickle Cell Disease and Opportunities for Quality Improvement

Hydroxyurea Prescription Fills and Adherence, Among Pediatric and Adult Medicaid Eligible Patients with Sickle Cell Disease in North Carolina

Beliefs and Practices Among Adults with Sickle Cell Disease Regarding Reproductive Health Decisions and Family Planning

Infection-Related Morbidity Reduced Overall Survival in a Large Real-World Cohort of Transplant Ineligible Newly Diagnosed Myeloma Patients Treated with UK Standard of Care

Programmed Cell Death Receptor (PD-1), PD-1 Ligand (PD-L1) Expression in Philadelphia Chromosome Negative Myeloid Neoplasms

Healthcare Utilization Patterns and Health Quality Indicators in Sickle Cell Disease Patients Transitioning from Pediatric to Adulthood

Opportunistic Infections, Is Non Hodgkin Lymphoma One of the Risk Factors for Mortality?

Outpatient Healthcare Utilization and Rates of Co-Management Among Medicaid Patients with Sickle Cell Disease in North Carolina

Evidence Based Recommendations for Supportive Care in Multiple Myeloma

Safety, Tolerability and Response Rates of Daratumumab in Patients with Relapsed Light Chain (AL) Amyloidosis: Results of a Phase II Study

The Conundrum of Hydroxyurea Use and Health Care Utilization in Sickle Cell Disease

Diagnosing and Managing Plasma Cell Disorders: Education Gaps in Primary Care Providers and Hematologist/Oncologists

Impact of Pneumococcal Vaccination on Multiple Myeloma

Using Project Echo Telementoring to Improve Sickle Cell Disease Care in the Midwest

Multiple Myeloma Vaccination Sequential Immune Response Pilot Study

Examining the Role of Bronchoscopy in Patients with Hematological Malignancies

Use of Marijuana in Patients with Sickle Cell Disease Increased the Frequency of Hospitalization for Acute Painful Vaso-Occlusive Crises

Retrospective Analysis of Seasonal Respiratory Viral Infections (SRVI) in Hematology, Lymphoma and Oncology Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only